Assetmark Inc. Buys 9,063 Shares of CME Group Inc. $CME

Assetmark Inc. increased its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 36.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,144 shares of the financial services provider’s stock after purchasing an additional 9,063 shares during the period. Assetmark Inc.’s holdings in CME Group were worth $9,411,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. Wayfinding Financial LLC bought a new stake in shares of CME Group during the 1st quarter valued at $25,000. Webster Bank N. A. raised its position in shares of CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares during the last quarter. Cornerstone Planning Group LLC raised its position in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Highline Wealth Partners LLC raised its position in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC raised its position in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 98 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Raymond James Financial dropped their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research report on Monday, October 13th. JPMorgan Chase & Co. upped their target price on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research report on Tuesday, October 14th. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Finally, Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $275.00 to $300.00 in a report on Thursday, September 25th. Eight investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $285.19.

Check Out Our Latest Report on CME

CME Group Price Performance

Shares of CME stock opened at $265.49 on Friday. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79. The firm has a market capitalization of $95.68 billion, a price-to-earnings ratio of 25.73, a price-to-earnings-growth ratio of 4.41 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a fifty day moving average of $265.83 and a 200-day moving average of $272.09.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.68 EPS. On average, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio is presently 48.45%.

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the transaction, the general counsel directly owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 in the last quarter. 0.30% of the stock is currently owned by company insiders.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.